Earnings History Data for Albireo Pharma, Inc. (ALBO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Albireo Pharma, Inc.
Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16-05-2022 | AH | 4:00 PM ET (May 16) |
ALBO | Albireo Pharma, Inc. | 550.01 | -2.19 | -2.02 | -2.29 | Albireo Pharma GAAP EPS of -$2.19 misses by $0.39, revenue of $6.83M misses by $0.42M [5/16/2022 4:24 PM] |
22.89 | -5.15 (-18.37%) |
26.50 | -1.54 (-5.49%) |
20.30 - 37.86 | 1,939,651 | 270,000 | 9,465 | |
|
||||||||||||||||||
| 01-03-2022 | PM | 8:30 AM ET (Mar 1) |
ALBO | Albireo Pharma, Inc. | 648.92 | -0.57 | -1.27 | -1.30 | Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52M [3/1/2022 8:41 AM] |
27.55 | -5.78 (-17.35%) |
33.34 | 0.0 (0.00%) |
20.30 - 38.38 | 982,432 | 240,000 | 200 | |
|
||||||||||||||||||
| 04-11-2021 | PM | 8:30 AM ET (Nov 4) |
ALBO | Albireo Pharma, Inc. | 586.72 | -1.26 | 0.54 | -1.96 | Albireo Pharma EPS beats by $2.41, misses on revenue [11/4/2021 8:36 AM] |
29.51 | -1.78 (-5.69%) |
28.00 | -3.29 (-10.51%) |
27.23 - 43.41 | 249,267 | 110,000 | 3,154 | |
| 05-08-2021 | PM | 8:30 AM ET (Aug 5) |
ALBO | Albireo Pharma, Inc. | 547.05 | -1.90 | -1.92 | -1.38 | Albireo Pharma EPS beats by $0.07, beats on revenue [8/5/2021 8:42 AM] |
30.05 | 2.51 (9.11%) |
27.55 | 0.01 (0.04%) |
22.78 - 49.00 | 210,056 | 270,000 | 321 | |
| 06-05-2021 | PM | 8:00 AM ET (May 6) |
ALBO | Albireo Pharma, Inc. | 580.48 | -2.29 | -1.72 | -2.23 | 30.19 | -0.21 (-0.69%) |
30.19 | 0.0 (0.00%) |
22.08 - 49.00 | 190,481 | 220,000 | 4,725 | ||
| 25-02-2021 | PM | 7:30 AM ET (Feb 25) |
ALBO | Albireo Pharma, Inc. | 701.66 | -1.30 | -1.90 | -0.57 | Albireo Pharma EPS beats by $0.59, beats on revenue [2/25/2021 8:05 AM] |
35.28 | -1.40 (-3.82%) |
37.44 | 0.76 (2.07%) |
11.26 - 49.00 | 193,798 | 188,466 | 1,849 | |
| 05-11-2020 | PM | ALBO | Albireo Pharma, Inc. | 601.82 | -1.96 | -1.48 | -1.73 | Albireo Pharma EPS misses by $0.45, beats on revenue [11/5/2020 7:47 AM] |
34.59 | 2.17 (6.69%) |
34.59 | 0.0 (0.00%) |
11.26 - 49.00 | 121,764 | 136,000 | 9,021 | ||
|
|
||||||||||||||||||
| 06-08-2020 | PM | ALBO | Albireo Pharma, Inc. | 392.76 | -1.38 | -1.65 | -1.35 | Albireo Pharma EPS beats by $0.28, beats on revenue [8/6/2020 7:40 AM] |
27.31 | 3.13 (12.94%) |
25.50 | 1.32 (5.46%) |
11.26 - 31.50 | 180,340 | 162,362 | 275 | ||
|
|
||||||||||||||||||